Quantitative aspects of T cell activation—peptide generation and editing by MHC class I molecules

Valitutti, 1995, Serial triggering of many T-cell receptors by a few peptide–MHC complexes, Nature, 375, 148, 10.1038/375148a0 Valitutti, 1997, Serial triggering of TCRs: a basis for the sensitivity and specificity of antigen recognition, Immunol Today, 18, 299, 10.1016/S0167-5699(97)80027-8 Davis, 1998, Ligand recognition by alpha beta T cell receptors, Annu Rev Immunol, 16, 523, 10.1146/annurev.immunol.16.1.523 Rogers, 1988, The PEST hypothesis, Science, 234, 364, 10.1126/science.2876518 Varshavsky, 1992, The N-end rule, Cell, 69, 725, 10.1016/0092-8674(92)90285-K Glotzer, 1991, Cyclin is degraded by the ubiquitin pathway, Nature, 349, 132, 10.1038/349132a0 Yewdell, 1996, Defective ribosomal products (DRiPs): a major source of antigenic peptides for MHC class I molecules?, J Immunol, 157, 1823, 10.4049/jimmunol.157.5.1823 Groll, 1997, Structure of 20S proteasome from yeast at 2.4 Angstrom resolution, Nature, 386, 463, 10.1038/386463a0 Hilt, 1996, Proteasomes: destruction as a programme, Trends Biochem Sci, 21, 96, 10.1016/S0968-0004(96)10012-8 Dick, 1996, Coordinated dual cleavages induced by the proteasome regulator PA28 lead to dominant MHC ligands, Cell, 86, 253, 10.1016/S0092-8674(00)80097-5 Niedermann, 1997, Potential immunocompetence of proteolytic fragments produced by proteasomes before evolution of the vertebrate immune system, J Exp Med, 186, 209, 10.1084/jem.186.2.209 Cox, 1995, Presentation of endogenous and exogenous antigens is not affected by inactivation of E1 ubiquitin-activating enzyme in temperature-sensitive cell lines, J Immunol, 154, 511, 10.4049/jimmunol.154.2.511 Michalek, 1993, A role for the ubiquitin-dependent proteolytic pathway in MHC class I-restricted antigen presentation, Nature, 363, 552, 10.1038/363552a0 Rock, 1994, Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules, Cell, 78, 761, 10.1016/S0092-8674(94)90462-6 Cerundolo, 1997, The proteasome-specific inhibitor lactacystin blocks presentation of cytotoxic T lymphocyte epitopes in human and murine cells, Eur J Immunol, 27, 336, 10.1002/eji.1830270148 Niedermann, 1995, Contribution of proteasome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility complex class I molecules, Immunity, 2, 289, 10.1016/1074-7613(95)90053-5 Eggers, 1995, The cleavage preference of the proteasome governs the yield of antigenic peptides, J Exp Med, 182, 1865, 10.1084/jem.182.6.1865 Groettrup, 1996, A role for the proteasome regulator PA28alpha in antigen presentation, Nature, 381, 166, 10.1038/381166a0 Ossendorp, 1996, A single residue exchange within a viral CTL epitope alters proteasome-mediated degradation resulting in lack of antigen presentation, Immunity, 5, 115, 10.1016/S1074-7613(00)80488-4 Rammensee, 1993, MHC molecules as peptide receptors, Curr Opin Immunol, 5, 35, 10.1016/0952-7915(93)90078-7 Dick, 1998, The making of the dominant MHC class I ligand SYFPEITHI, Eur J Immunol, 28, 2478, 10.1002/(SICI)1521-4141(199808)28:08<2478::AID-IMMU2478>3.0.CO;2-U Falk, 1990, Cellular peptide composition governed by major histocompatibility complex class I molecules, Nature, 348, 248, 10.1038/348248a0 Beninga, 1998, Interferon-gamma can stimulate post-proteasomal trimming of the N terminus of an antigenic peptide by inducing leucine aminopeptidase, J Biol Chem, 273, 18734, 10.1074/jbc.273.30.18734 Wilk, 1998, Purification, characterization, and cloning of a cytosolic aspartyl aminopeptidase, J Biol Chem, 273, 15961, 10.1074/jbc.273.26.15961 Glas, 1998, A proteolytic system that compensates for loss of proteasome function, Nature, 392, 618, 10.1038/33443 Coux, 1996, Structure and functions of the 20S and 26S proteasomes, Annu Rev Immunol, 65, 801 Cardozo, 1994, Evidence that the nature of amino acid residues in the P3 position directs substrates to distinct catalytic sites of the pituitary multicatalytic proteinase complex (proteasome), Biochemistry, 33, 6483, 10.1021/bi00187a014 Vinitsky, 1994, Inhibition of the proteolytic activity of the multicatalytic proteinase complex (proteasome) by substrate-related peptidyl aldehydes, J Biol Chem, 269, 29860, 10.1016/S0021-9258(18)43960-9 del, 1991, Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein, Cell, 66, 1145, 10.1016/0092-8674(91)90037-Y Craiu, 1997, Lactacystin and clasto-lactacystin beta-lactone modify multiple proteasome beta-subunits and inhibit intracellular protein degradation and major histocompatibility complex class I antigen presentation, J Biol Chem, 272, 13437, 10.1074/jbc.272.20.13437 Stoltze, 1998, Generation of the vesicular stomatitis virus nucleoprotein cytotoxic T lymphocyte epitope requires proteasome-dependent and -independent proteolytic activities, Eur J Immunol, 28, 4029, 10.1002/(SICI)1521-4141(199812)28:12<4029::AID-IMMU4029>3.0.CO;2-N Heinemeyer, 1997, The activ e sites of the eukaryotic 20S proteasome and their involvement in subunit precursor processing, J Biol Chem, 272, 25200, 10.1074/jbc.272.40.25200 Nussbaum, 1998, Cleavage motifs of the yeast 20S proteasome beta-subunits deduced from digests of enolase 1, Proc Natl Acad Sci USA, 95, 12504, 10.1073/pnas.95.21.12504 Shimbara, 1998, Contribution of proline residue for efficient production of MHC class I ligands by proteasomes, J Biol Chem, 273, 23062, 10.1074/jbc.273.36.23062 Wenzel, 1998, Existence of a molecular ruler in proteasomes suggested by analysis of degradation products, FEBS Lett, 349, 205, 10.1016/0014-5793(94)00665-2 Androlewicz, 1993, Evidence that transporters associated with antigen processing translocate a major histocompatibility complex class I-binding peptide into the endoplasmic reticulum in an ATP-dependent manner, Proc Natl Acad Sci USA, 90, 9130, 10.1073/pnas.90.19.9130 Shepherd, 1993, TAP1-dependent peptide translocation in vitro is ATP dependent and peptide selective, Cell, 74, 577, 10.1016/0092-8674(93)80058-M Neefjes, 1993, Selective and ATP-depen dent translocation of peptides by the MHC- encoded transporter, Science, 261, 769, 10.1126/science.8342042 Koopmann, 1997, Generation, intracellu lar transport and loading of peptides associated with MHC class I molecules, Curr Opin Immunol, 9, 80, 10.1016/S0952-7915(97)80163-X Pamer, 1998, Mechanisms of MHC class I-restricted antigen processing, Annu Rev Immunol, 16, 323, 10.1146/annurev.immunol.16.1.323 Srivastava, 1994, Heat shock proteins transfer peptides during antigen processing and CTL priming, Immunogenetics, 39, 93, 10.1007/BF00188611 Arnold, 1995, Cross-priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96, J Exp Med, 182, 885, 10.1084/jem.182.3.885 Srivastava, 1998, Heat shock proteins come of age: primitive functions acquire new roles in an adaptive world, Immunity, 8, 657, 10.1016/S1074-7613(00)80570-1 Lammert, 1997, Prot ein disulfide isomerase is the dominant acceptor for peptides translocated into the endoplasmic reticulum, Eur J Immunol, 27, 1685, 10.1002/eji.1830270714 Spee, 1997, TAP-translocated peptides specifically bind pr oteins in the endoplasmic reticulum, including gp96, protein disulfide isomerase and calreticulin, Eur J Immunol, 27, 2441, 10.1002/eji.1830270944 Koopmann, 1996, Translocation of long peptides by transporters associated with antigen processing (TAP), Eur J Immunol, 26, 1720, 10.1002/eji.1830260809 Anderson, 1991, Endogenously synthesized peptide with an endoplasmic reticulum signal sequence sensitizes antigen processing mutant cells to class I-restricted cell-mediated lysis, J Exp Med, 174, 489, 10.1084/jem.174.2.489 Elliott, 1995, Processing of major histocompatibility class I-restricted antigens in the endoplasmic reticulum, J Exp Med, 181, 1481, 10.1084/jem.181.4.1481 Rammensee, 1993, Peptides naturally presented by MHC class I molecules, Annu Rev Immunol, 11, 213, 10.1146/annurev.iy.11.040193.001241 Hunt, 1992, Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry, Science, 255, 1261, 10.1126/science.1546328 Tsomides, 1991, An optimal viral peptide recognized by CD8+T cells binds very tightly to the restricting class I major histocompatibility complex protein on intact cells but not to the purified class I protein, Proc Natl Acad Sci USA, 88, 11276, 10.1073/pnas.88.24.11276 Christinck, 1991, Peptide binding to class I MHC on living cells and quantitation of complexes required for CTL lysis, Nature, 352, 67, 10.1038/352067a0 Falk, 1991, Identification of naturally processed viral nonapeptides allows their quantification in infected cells and suggests an allele-specific T cell epitope forecast, J Exp Med, 174, 425, 10.1084/jem.174.2.425 McMichael, 1993, Natural selection at work on the surface of virus-infected cells, Science, 260, 1771, 10.1126/science.8511585 Falk, 1993, Allele-specific ligand motifs of HLA-C molecules, Proc Natl Acad Sci USA, 90, 12005, 10.1073/pnas.90.24.12005 Rötzschke, 1993, Qa-2 molecules are peptide receptors of higher stringency than ordinary class I molecules, Nature, 361, 642, 10.1038/361642a0 Korber, 1987, Regulation of murine class I genes by interferons is controlled by regions located both 5′ and 3′ to the transcription initiation site, Proc Natl Acad Sci USA, 84, 3380, 10.1073/pnas.84.10.3380 Fruh, 1997, Inhibition of MHC class I antigen processing by viral proteins, J Mol Med, 75, 18, 10.1007/s001090050082 Van Bleek, 1990, Isolation of an endogenously processed immunodominant viral peptide from the class I H-2Kbmolecule, Nature, 348, 213, 10.1038/348213a0 Falk, 1991, Alle le-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules, Nature, 351, 290, 10.1038/351290a0 Schmidt, 1997, Cell-free tumor antigen peptide-based cancer vaccines, Proc Natl Acad Sci USA, 94, 3262, 10.1073/pnas.94.7.3262 Pamer, 1994, Direct sequence identification and kinetic analysis of an MHC class I-restricted Listeria monocytogenes CTL epitope, J Immunol, 152, 686, 10.4049/jimmunol.152.2.686 Henderson, 1993, Direct identification of an endogenous peptide recognized by multiple HLA-A2.1-specific cytotoxic T cells, Proc Natl Acad Sci USA, 90, 10275, 10.1073/pnas.90.21.10275 Demotz, 1989, Characterization of a naturally processed MHC class II-restricted T-cell determinant of hen egg lysozyme, Nature, 342, 682, 10.1038/342682a0 Wallny, 1992, Identification and quantification of a naturally presented peptide as recognized by cytotoxic T lymphocytes specific for an immunogenic tumor variant, Int Immunol, 4, 1085, 10.1093/intimm/4.10.1085 Rotzschke, 1991, Exact prediction of a natural T cell epitope, Eur J Immunol, 21, 2891, 10.1002/eji.1830211136 Brower, 1994, Minimal requirements for peptide mediated activation of CD8+CTL, Mol Immunol, 31, 1285, 10.1016/0161-5890(94)90079-5 Sykulev, 1996, Evidence that a single peptide–MHC complex on a target cell can elicit a cytolytic T cell response, Immunity, 4, 565, 10.1016/S1074-7613(00)80483-5 Rötzschke, 1997, Superactivation of an immune response triggered by oligomerized T cell epitopes, Proc Natl Acad Sci USA, 94, 14642, 10.1073/pnas.94.26.14642 Jardetzky, 1991, Identification of self peptides bound to purified HLA-B27, Nature, 353, 326, 10.1038/353326a0 Duncan, 1982, How many proteins are there in a typical mammalian cell?, Clin Chem, 28, 749, 10.1093/clinchem/28.4.749 Celis, 1995, The human keratinocyte two-dimensional gel protein database (update 1995): mapping components of signal transduction pathways, Electrophoresis, 16, 2177, 10.1002/elps.11501601355 Falk, 1994, Analysis of a naturally occurring HLA class I-restricted viral epitope, Immunology, 82, 337 Reddehase, 1989, A pentapeptide as minimal antigenic determinant for MHC class I-restricted T lymphocytes, Nature, 337, 651, 10.1038/337651a0 Schulz, 1991, Major histocompatibility complex binding and T cell recognition of a viral nonapeptide containing a minimal tetrapeptide, Eur J Immunol, 21, 1181, 10.1002/eji.1830210513 Rammensee, 1997 Ruppert, 1993, Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules, Cell, 74, 929, 10.1016/0092-8674(93)90472-3 Zinkernagel, 1974, Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system, Nature, 1974, 701, 10.1038/248701a0 Klavinskis, 1990, Vaccination and protection from a lethal viral infection: identification, incorporation, and use of a cytotoxic T lymphocyte glycoprotein epitope, Virology, 178, 393, 10.1016/0042-6822(90)90336-P Gallimore, 1998, A protective cytotoxic T cell response to a subdominant epitope is influenced by the stability of the MHC class I peptide complex and the overall spectrum of viral peptides generated within infected cells, Eur J Immunol, 28, 3301, 10.1002/(SICI)1521-4141(199810)28:10<3301::AID-IMMU3301>3.0.CO;2-Q Gavioli, 1993, Multiple A11-restricted cytotoxic T lymphocyte epitopes of different immunogenicities in the Epstein–Barr virus-encoded nuclear antigen 4, J Virol, 67, 1572, 10.1128/JVI.67.3.1572-1578.1993 Sijts, 1996, Two Listeria monocytogenes CTL epitopes are processed from the same antigen with different efficiencies, J Immunol, 156, 685, 10.4049/jimmunol.156.2.683 Pamer, 1991, Precise prediction of a dominant class I MHC-restricted epitope of Listeria monocytogenes, Nature, 353, 852, 10.1038/353852a0 Bruder, 1998, Efficient induction of cytotoxic CD8(+) T cells against exogenous proteins: establishment and characterization of a T cell line specific for the membrane protein ActA of Listeria monocytogenes, Eur J Immunol, 28, 2630, 10.1002/(SICI)1521-4141(199809)28:09<2630::AID-IMMU2630>3.0.CO;2-Z Hill, 1992, Molecular analysis of the association of HLA-B53 and resistance to severe malaria, Nature, 360, 434, 10.1038/360434a0